Flagship Biosciences Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 83

Employees

  • Latest Deal Type
  • M&A

Flagship Biosciences General Information

Description

Developer of a spatial biology and biomarker analytics platform designed to improve drug development and diagnostics. The company's technology utilizes patented AI image analysis and computational tissue interpretation to deliver quantitative measurements on every cell, enabling customers to identify missed biomarkers, stratify patients for clinical trials, and accelerate the development of precision therapeutics through integrated CLIA-certified laboratory services.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • 11800 Ridge Parkway
  • Suite 450
  • Broomfield, CO 80021
  • United States
+1 (303)
Primary Industry
Discovery Tools (Healthcare)
Parent Company
Corporate Office
  • 11800 Ridge Parkway
  • Suite 450
  • Broomfield, CO 80021
  • United States
+1 (303)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Flagship Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 06-Oct-2026 Completed Generating Revenue
4. Later Stage VC (Series C) 18-Feb-2024 Completed Generating Revenue
3. Later Stage VC (Series B1) 31-Aug-2022 Completed Generating Revenue
2. Debt - PPP 14-Apr-2020 $614K $3.5M Completed Generating Revenue
1. Later Stage VC (Series A) 09-Jul-2018 $3.5M $3.5M Completed Generating Revenue
To view Flagship Biosciences’s complete valuation and funding history, request access »

Flagship Biosciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C
Series B-3
Series B-2
Series B-1
Series A-2 4,278,829 $0.000100 6% $0.72 $0.72 1x $0.72 7.57%
Series A-1 2,256,109 $0.000100 6% $0.54 $0.54 1x $0.54 3.99%
To view Flagship Biosciences’s complete cap table history, request access »

Flagship Biosciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a spatial biology and biomarker analytics platform designed to improve drug development and diagnostics. Th
Discovery Tools (Healthcare)
Broomfield, CO
83 As of 2024

Beverly, MA
 

San Jose, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Flagship Biosciences Competitors (30)

One of Flagship Biosciences’s 30 competitors is Genomic Expression, a Venture Capital-Backed company based in Beverly, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Genomic Expression Venture Capital-Backed Beverly, MA
Molecular Devices Corporate Backed or Acquired San Jose, CA
Cytena Formerly VC-backed Freiburg, Germany
Unchained Labs Private Equity-Backed Pleasanton, CA
Sphere Fluidics Formerly VC-backed Cambridge, United Kingdom
You’re viewing 5 of 30 competitors. Get the full list »

Flagship Biosciences Patents

Flagship Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-11568536-B2 Method for digitally generating scores for multiple diagnostic tests from tissue assayed with a single test Active 29-Apr-2020
US-20210343004-A1 Method for digitally generating scores for multiple diagnostic tests from tissue assayed with a single test Active 29-Apr-2020
US-11449972-B2 Method for aligning digital images of tissue sections using tissue object correspondences Active 14-Oct-2019
US-20210110519-A1 Method for aligning digital images of tissue sections using tissue object correspondences Active 14-Oct-2019
US-20200342588-A1 Methods for determining biological relevance of object clustering within tissue samples Inactive 26-Apr-2019 G06T7/0012
To view Flagship Biosciences’s complete patent history, request access »

Flagship Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Flagship Biosciences Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Ampersand Capital Partners Growth/Expansion Minority
BroadOak Capital Partners Growth/Expansion Minority
Research Corporation Technologies Venture Capital Minority
To view Flagship Biosciences’s complete investors history, request access »

Flagship Biosciences Acquisitions (2)

Flagship Biosciences’s most recent deal was a Merger/Acquisition with Interpace Pharma Solutions. The deal was made on 31-Aug-2022.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Interpace Pharma Solutions 31-Aug-2022 Merger/Acquisition Other Pharmaceuticals and Biotechnology
IHCtech 20-May-2012 Merger/Acquisition Laboratory Services (Healthcare)
To view Flagship Biosciences’s complete acquisitions history, request access »

Flagship Biosciences FAQs

  • When was Flagship Biosciences founded?

    Flagship Biosciences was founded in 2009.

  • Where is Flagship Biosciences headquartered?

    Flagship Biosciences is headquartered in Broomfield, CO.

  • What is the size of Flagship Biosciences?

    Flagship Biosciences has 83 total employees.

  • What industry is Flagship Biosciences in?

    Flagship Biosciences’s primary industry is Discovery Tools (Healthcare).

  • Is Flagship Biosciences a private or public company?

    Flagship Biosciences is a Private company.

  • What is Flagship Biosciences’s current revenue?

    The current revenue for Flagship Biosciences is .

  • How much funding has Flagship Biosciences raised over time?

    Flagship Biosciences has raised $46.7M.

  • Who are Flagship Biosciences’s investors?

    Ampersand Capital Partners, BroadOak Capital Partners, and Research Corporation Technologies have invested in Flagship Biosciences.

  • Who are Flagship Biosciences’s competitors?

    Genomic Expression, Molecular Devices, Cytena, Unchained Labs, and Sphere Fluidics are some of the 30 competitors of Flagship Biosciences.

  • When was Flagship Biosciences acquired?

    Flagship Biosciences was acquired on 06-Oct-2026.

  • Who acquired Flagship Biosciences?

    Flagship Biosciences was acquired by Lanterne Dx.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process